Chinese stem cell therapy reverses heart failure in 90% of patients in landmark trial

drug approval expired 87% Health

A hospital in East China has conducted a landmark trial using reprogrammed stem cells to treat severe heart failure, with 90% of patients showing significant heart function recovery. This advancement marks a promising breakthrough in regenerative medicine.

🇨🇳 Location: Nanjing — Sources: 2 — First seen: — Last seen:
stem cell therapy heart failure clinical trial regenerative medicine China

Linked Entities

Nanjing Drum Tower Hospital

organization involved

Nanjing University

organization involved

Akeso

organization involved

China's National Medical Products Administration

organization involved

Contributing Articles